ProMetic Life Sciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ProMetic Life Sciences

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext

From: axial	4/13/2016 6:19:13 PM
	Read Replies (1) of 250

Equities Analysts Offer Predictions for ProMetic Life Sciences Inc.’s Q1 2016 Earnings (PLI) April 4th, 2016 'ProMetic Life Sciences Inc. (TSE:PLI) – Stock analysts at Scotiabank issued their Q1 2016 earnings estimates for shares of ProMetic Life Sciences in a research note issued on Thursday, Zacks Investment Research reports. Scotiabank analyst A. Ridgeway expects that the firm will post earnings of ($0.03) per share for the quarter. Scotiabank also issued estimates for ProMetic Life Sciences’ Q2 2016 earnings at ($0.03) EPS, Q3 2016 earnings at ($0.03) EPS and Q4 2016 earnings at ($0.03) EPS. A number of other analysts also recently issued reports on the stock. Paradigm Capital increased their price target on shares of ProMetic Life Sciences from C$2.90 to C$3.30 and gave the stock a “buy” rating in a report on Monday, March 28th. CIBC began coverage on ProMetic Life Sciences in a research report on Monday, March 21st. They set a “sector outperformer” rating and a C$5.00 target price on the stock. RBC Capital restated an “outperform” rating and issued a C$4.50 price target on shares of ProMetic Life Sciences in a research note on Tuesday, December 8th. Finally, Panmure Gordon upped their price target on ProMetic Life Sciences to C$6.70 and gave the stock a “buy” rating in a report on Friday, January 29th. Six analysts have rated the stock with a buy rating, The company currently has a consensus rating of “Buy” and a consensus target price of C$4.83.' Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Next 10PreviousNext